Meckley, Lisa M <br/><br/>
Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials.  [electronic resource] 

 -  BMC immunology  05 2020 
 - 24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2172 
<br/><br/><label>Standard No.: </label>10.1186/s12865-020-00346-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Child<br/>Child, Preschool<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Female<br/>Glycolipids--immunology<br/>Humans<br/>Immunoglobulins, Intravenous--immunology<br/>Male<br/>Middle Aged<br/>Primary Immunodeficiency Diseases--immunology<br/>Quality of Life<br/>Young Adult